Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia

Biological Psychiatry

Volumn 41, Issue 9, 1997, Pages 985-987

  Chen, Chia Hsiang ^a,b,f   Lee, Yu Ru ^a   Wei, Fu Chuan ^c   Koong, Farn Jong ^c   Hwu, Hai Gwo ^d   Hsiao, Kwang Jen ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c Hung Chi Psychiatric Hospital   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f NONE   (Taiwan)

Author keywords

association; catechol O methyltransferase; genetics; polymo rphism; schizophrenia; susceptibility

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TAIWAN;

ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SCHIZOPHRENIA;

EID: 0030984889     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00045-0     Document Type: Article

References (13)

1. Axelrod J, Tomchick R (1958): Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705.
2. Baron M, Gruen R, Levitt M, Hunter C, Asnis L (1984): Erythrocyte catechol O-methyltransferase activity in schizophrenia: Analysis of family data. Am J Psychiatry 141:29-32.
3. Daniels JK, Williams MM, Williams J, et al (1996): No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 153:268-270.
4. Kelly D, Goldberg R, Wilson D, et al (1993): Confirmation that the velo-cardio-facial syndrome is associated with haploinsufficiency of genes at chromosome 22q11. Am J Med Gene? 45:308-312.
5. Kety SS (1967): Current biochemical approaches to schizophrenia. N Engl J Med 276:325-331.
6. Lasseter VK, Pulver AE, Wolyniec PS, et al (1995): Follow-up report of potential linkage for schizophrenia on chromosome 22q: Part 3. Am J Med Genet 60:172-173.
7. Lotta T, Vidgren J, Tilgmann C, et al (1995): Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
8. Matthysse S, Baldessarini RJ (1972): S-adenosylmethionine and catechol-O-methyltransferase in schizophrenia. Am J Psychiatry 128:1310-1312.
9. Risch N, Merikangas K (1996): The future of genetic studies of complex human diseases. Science 273:1516-1517.
10. Schwab SG, Lerer B, Albus M, et al (1995): Potential linkage for schizophrenia on chromosome 22q12-q13: A replication study. Am J Med Genet 60:436-443.
11. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion R (1992): Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141-142.
12. Spielman RS, McGinnis RE, Ewens WJ (1993): Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
13. Winqvist R, Lundstrom K, Salminen M, Laatikainen M, Ulmanen (1992): The human catechol-O-methyltransferase (COMT) gene maps to band qll.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet 59:253-257.